文献
J-GLOBAL ID:202102225739344072
整理番号:21A2516777
BRCA変異と相同組換え欠損状態による白金感受性再発卵巣癌患者におけるオラパリブ治療:第II相LIGHT研究からの二次有効性結果【JST・京大機械翻訳】
Olaparib treatment in patients with platinum-sensitive relapsed ovarian cancer by BRCA mutation and homologous recombination deficiency status: secondary efficacy results from the phase II LIGHT study
著者 (12件):
Cadoo Karen
(Memorial Sloan Kettering Cancer Center, New York, NY, United States)
,
Simpkins Fiona
(Jordan Center for Gynecologic Oncology at the Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, United States)
,
Mathews Cara
(Women & Infants Hospital, Brown University, Providence, RI, United States)
,
Liu Ying
(Memorial Sloan Kettering Cancer Center, New York, NY, United States)
,
Provencher Diane
(CHUM Gynecologie-Oncologie, Montreal, QC, Canada)
,
McCormick Colleen
(Legacy Medical Group Gynecologic Oncology, Portland, Oregon, United States)
,
ElNaggar Adam
(West Cancer Center and Research Institute, Memphis, TN, United States)
,
Kabil Nashwa
(AstraZeneca, Gaithersburg, MD, United States)
,
Bennett James
(AstraZeneca, Gaithersburg, MD, United States)
,
Yu Hong
(AstraZeneca, Gaithersburg, MD, United States)
,
Munley Jiefen
(AstraZeneca, Gaithersburg, MD, United States)
,
Aghajanian Carol
(Memorial Sloan Kettering Cancer Center, New York, NY, United States)
資料名:
Gynecologic Oncology
(Gynecologic Oncology)
巻:
162
号:
S1
ページ:
S217
発行年:
2021年
JST資料番号:
E0561C
ISSN:
0090-8258
資料種別:
逐次刊行物 (A)
記事区分:
短報
発行国:
オランダ (NLD)
言語:
英語 (EN)